Eleni Andreopoulou, M.D. | Patient Care

Dr. Eleni Andreopoulou

Claim this profile

NYP/Weill Cornell Medical Center

Studies Breast Cancer
Studies Breast cancer
11 reported clinical trials
25 drugs studied

Area of expertise

1Breast Cancer
Eleni Andreopoulou has run 10 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 positive
ER positive
2Breast Cancer
Eleni Andreopoulou has run 6 trials for Breast cancer. Some of their research focus areas include:
HER2 positive
HER2 negative
ER positive

Affiliated Hospitals

Image of trial facility.
NYP/Weill Cornell Medical Center
Image of trial facility.
Weill Cornell Medicine

Clinical Trials Eleni Andreopoulou is currently running

Image of trial facility.

Vaccine + Chemotherapy + Immunotherapy

for Breast Cancer

This phase II trial studies how well nab-paclitaxel, durvalumab, and tremelimumab with or without personalized synthetic long peptide vaccine (neoantigen vaccine) works in treating patients with triple negative breast cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as nab-paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as durvalumab and tremelimumab, may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Vaccines made from peptides may help the body build an effective immune response to kill tumor cells. It is not yet known whether giving nab-paclitaxel, durvalumab, and tremelimumab with or without neoantigen vaccine will work better in treating patients with triple negative breast cancer.
Recruiting1 award Phase 222 criteria

More about Eleni Andreopoulou

Clinical Trial Related7 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Eleni Andreopoulou has experience with
  • Trastuzumab
  • Ladiratuzumab Vedotin
  • Palbociclib
  • Pertuzumab
  • Fulvestrant
  • Surgery
Breakdown of trials Eleni Andreopoulou has run
Breast Cancer
Breast cancer
Parotid Gland Cancer
Cancer
Vulval Intraepithelial Neoplasia

Other Doctors you might be interested in

Brian DeRubertisNew York Presbyterian Hospital/Cornell University
Jennifer M. LevineNYP/Weill Cornell Medical Center
Dmitriy Feldman, MDWeill Cornell Medical College/The New York Presbyterian Hospital

Frequently asked questions

Do I need insurance to participate in a trial?
What does Eleni Andreopoulou specialize in?
Is Eleni Andreopoulou currently recruiting for clinical trials?
Are there any treatments that Eleni Andreopoulou has studied deeply?
What is the best way to schedule an appointment with Eleni Andreopoulou?
What is the office address of Eleni Andreopoulou?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security